MicroRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Số trang: 8
Loại file: pdf
Dung lượng: 682.88 KB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict.
Nội dung trích xuất từ tài liệu:
MicroRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Nội dung trích xuất từ tài liệu:
MicroRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Uterine cervical neoplasm Cervical cancer Formalin-fixed paraffin-embedded Cox proportional hazards model Human papillomavirusGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 117 0 0 -
6 trang 102 0 0
-
12 trang 92 0 0
-
19 trang 74 0 0
-
17 trang 62 0 0
-
9 trang 40 0 0
-
12 trang 37 0 0